OSE Immunotherapeutics SA announced the appointment of Julien Perrier as chief commercial officer. Mr. Perrier has an extensive background in marketing and commercialization of leading immunotherapy products and will be the founding member of the Company’s new Boston-based, U.S. global development team specialized in immunotherapy. Most recently, Mr. Perrier was head of the immunology division, France, at AbbVie, where he oversaw the commercial operations for Humira as well as preparations for the launch of two additional immunology products. From 2013 to 2017, Mr. Perrier was head of operations and portfolio management at the biological products division of Sanofi in partnership with Regeneron, specializing in immunology.